A full biological cure is the ultimate and permanent solution to all the complexity and problems of T1D. The delivery of that cure would mean the fulfillment of JDRF’s vision of a world without T1D.
We now know that the human body has an amazing ability to heal itself. For a decade, JDRF has been exploring ways to restore the body’s ability to produce insulin while preventing the autoimmune attack that triggers T1D. We’ve funded dozens of human trials to test various immune interventions, and each one has added to our understanding of what’s necessary to stop the immune attack. Together, these areas of investigation will eventually yield a permanent cure for T1D.
Research to cure T1D still represents the majority of JDRF’s research portfolio and we’ve made tremendous progress over the years.
But restoring the body’s ability to create new beta cells while simultaneously preventing recurrence of the deadly autoimmune attack is the greatest challenge yet. We’re working to accomplish something that no one else has: permanently turning off an autoimmune response. We’re confident it can be done, and JDRF is leading the way in funding research aimed at this historic goal.
JDRF researchers have already demonstrated that the body has the ability to grow new beta cells in certain situations, such as pregnancy. Even those with long-term T1D have shown they can still grow beta cells. Now, JDRF is advancing a number of approaches to trigger the body’s ability to do the same in all those with T1D. JDRF is also exploring how to reprogram other cells in the body to become beta cells. And we’re exploring ways the pancreas can become its own source of new beta cells.
At the same time, we’ve discovered a number of suspected triggers associated with the onset of T1D, including certain viruses. This has opened the door to the development of new approaches that would prevent the destructive immune system response in T1D. This might take the form of a viral vaccine, similar to the polio vaccine, or it might be a therapy similar to an allergy shot, which would educate or reeducate the body’s immune system not to initiate an attack on the beta cells.
In the last decade the field of regenerative medicine has exploded. JDRF has been, and with your support will remain, at the forefront of this scientific revolution. But we still need tens of millions of dollars to continue the progress. Support the most promising route to a cure and together we can finally change Type One into Type None.
Help turn Type One into Type None.
- Availability for T1Ds:
- Long term
- Current Need:
- $65 million
- Anticipated 5-year need:
- $150+ million
Every dollar will help bring us closer to a world without T1D. Please consider a donation today.Donate Now
Want to know more about beta cell encapsulation and get updates about this life-changing therapy? Download our white paper and stay informed.White Paper